Participate in Respiratory Clinical Research
Understanding Respiratory Conditions and Research
- Led by Dr. Frank Hull a physician board-certified in both Pulmonary and Critical care medicine
The Burden of Pulmonary Diseases:
Asthma
Affects over 300 million people worldwide
Studies focusing on:
New biologics for severe asthma
Novel inhaler combinations
Long-acting treatments for better symptom control
Reducing exacerbation frequency
COPD (Chronic Obstructive Pulmonary Disease)
- Impacts 1 in 7 adults over 40
- Current research exploring:
- Novel new anti-inflammatory approaches
- Treatments to reduce flare-ups
- Solutions to reduce symptoms
- Studying if control of COPD causes less heart attacks.
Chronic Neuropathic Cough (Coughing for more that 1 year)
- Affects up to 10% of adults
- Studies investigating:
- Novel nerve-targeting medications
- Quality of life improvements
- Part of our comprehensive respiratory research program
Bronchiectasis
- Chronic condition of infection and inflamation that permanently damages the lung airways
- Research focused on:
- Preventing exacerbations and need for rescue antibiotics
- Managing daily symptoms
- Stopping further damage to the airways
Screening Forms:
COPD
Bronchiectasis
Asthma
Why Research Participation Matters
Clinical Trial Outcomes
Research shows that study participants often experience better health outcomes:
- 20% better monitoring of their condition
- Earlier detection of health changes
- More frequent medical assessments
- Better understanding of their condition
- Improved outcomes even in placebo groups due to enhanced care
- Access to new treatments before they become widely available
Phase III & IV Studies
- We also conduct later-phase studies using medications that have:
- Already FDA approved for other uses and already on the market
- Established safety profiles
- Proven effectiveness in earlier trials
What Study Participants Receive
Medical Care
- Comprehensive health assessments
- Advanced diagnostic testing as per protocol:
- Pulmonary function tests
- Blood work analysis
- CT of lungs and imaging when needed
- Regular health monitoring during visits
- Study medications for free
- Additional baseline respiratory medications usually continued as per protocol
Support Services
- Transportation assistance
- Flexible scheduling
- Comfortable study facilities
Expert Research Leadership
Meet Our Principal Investigator – Dr. Frank P. Hull, MD
Comprehensive Training & Expertise
- Board Certified in:
- Internal Medicine
- Pulmonary Medicine
- Critical Care Medicine
- Sleep Medicine
- Full Clinical Professor of Medicine at Nova Southeastern University
- Training and practice experience across four countries
- Specialized expertise in respiratory medicine, critical care, and clinical research
Current Research Focus Areas
Dr. Hull specializes in cutting-edge medicine and research across multiple respiratory conditions:
- Pulmonary pharmaceutical trials
- Interventional pulmonology and lung cancer
- Pulmonary fibrosis and interstitial lung disease
- Advanced COPD and Alpha-1 treatments
- Severe asthma management
- Bronchiectasis
- COVID-19 therapies
- Pulmonary arterial hypertension
- Multi-drug resistant infections
- Sleep disorders
The Participation Process
What Study Participants Receive
Clinical trial participants receive comprehensive care and support at no cost. Here is what you can expect:
🏥
Study-Related Medical Care
All medical visits, tests, and procedures related to the clinical trial are provided at no charge to you or your insurance.
🧪
Advanced Diagnostic Testing
Comprehensive lab work, lung function testing (spirometry), CT imaging, and specialized diagnostics — all at no cost.
💊
Study Medications
All study medications are provided free of charge. Your current baseline respiratory medications are usually continued as per the study protocol.
💰
Visit Compensation
Monetary compensation for each study visit to cover your time and any inconvenience.
🚗
Travel Support
Mileage reimbursement or transportation assistance for qualifying participants. Flexible scheduling to work around your routine.
🅿️
Free Parking
Complimentary parking at our clinic during all study visits.
Screen for a Clinical Trial Now
Complete a quick screening form to see if you may qualify for one of our current studies. It takes just a few minutes and our research team will follow up with you personally.
🫁
COPD
Chronic Obstructive Pulmonary Disease
Ages 40-85 with flare-ups requiring steroids or antibiotics. Current or former smokers on inhaler therapy.
🔬
Bronchiectasis
Non-Cystic Fibrosis Bronchiectasis
Ages 18-85 with confirmed bronchiectasis, chronic mucus production, and recurrent infections.
💨
Asthma
Asthma with Exacerbations
Patients with asthma experiencing frequent flare-ups despite current inhaler treatment.
Ready to Participate?
Contact our research team today or fill out a screening form to find out if you qualify.